RxDoctor Payments Data

Charlotte Agnone, MD

Integrative Medicine · Dublin, OHNPI 1255446894

Payments from drug & device makers

$62,952in general payments, 2019–2025

Across 97 payments — averaging $648.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$31K
  • Optovue, Inc.$30K
  • Amgen$411
  • Johnson & Johnson Surgical Vision, Inc.$241
  • Alcon$157
  • Aerie Pharmaceuticals, Inc.$148
  • plus $778 from 15 others

What the payments were for

  • Speaking & faculty fees$15,00047%
  • Food & beverage$2,0877%
  • Gifts$15,00047%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few integrative medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$361,370
Medicare patients
877
Services billed
3,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine57$49,869
XdemvyLotilaner26$47,328
XiidraLifitegrast14$14,215
LumiganBimatoprost29$12,780
MieboPerfluorohexyloctane/Pf18$12,708
Prednisolone Acetate280$10,945
Cyclosporine15$8,290
CombiganBrimonidine Tartrate/Timolol13$4,179
Latanoprost407$3,488
Ketorolac Tromethamine172$2,714
Azelastine Hcl92$2,606
Bromfenac Sodium12$2,443
SimbrinzaBrinzolamide/Brimonidine Tart12$2,398
Fluorometholone22$1,700
Timolol Maleate173$1,637

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan, Combigan$31,217$66,82799 claims
Tarsus Pharmaceuticals, Inc.Xdemvy$119$47,32826 claims
Bausch & Lomb Americas Inc.Xiidra, Miebo$95$26,92332 claims
AlconSimbrinza$157$2,39812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few integrative medicine providers in Ohioon file to place this against a meaningful peer group, so we don't.

Other integrative medicine in Dublin

Where these figures come from

Is this you, or does something look wrong? →